The founder of this company presented at the CHI HCV drug discovery conference back in the end of april. the presentation was, to say the least, underwhelming. But it's novel, and of course if there's a glimmer of a chance of there being something of value, she'll have the advisors lining up. I wouldn't hold my breath for this one.
Market Data 
Markets 
AI
